Cocrystal Pharma, Inc. (NASDAQ: COCP) is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of COVID-19 and other coronaviruses, influenza viruses, and noroviruses. Cocrystal employs unique structure-based technologies and Nobel Prize winning expertise to create first- and best-in-class antiviral drugs. The company is enrolling subjects in a Phase 1 trial with an antiviral candidate for pandemic and seasonal influenza A, and plans to initiate COVID-19 clinical trials in 2022 with an orally administered and inhalation/pulmonary delivered antiviral candidates.
View Top Employees from Cocrystal Pharma, Inc.Website | http://www.cocrystalpharma.com |
Ticker | COCP |
Revenue | $6 million |
Employees | 17 (14 on RocketReach) |
Founded | 2004 |
Address | 19805 N. Creek Parkway, Bothell, Washington 98011, US |
Phone | (786) 459-1831 |
Fax | (404) 601-1431 |
Technologies |
JavaScript,
HTML,
Twitter
+15 more
(view full list)
|
Industry | Biotechnology, Biotechnology Research, Pharmaceuticals, Therapeutic Devices, Antiviral Therapeutics, Healthcare, Science and Engineering, Small Molecule Therapeutics, Clinical Trials, Chronic Viral Diseases, Health Care, Therapeutics, Replication Enzymes |
Web Rank | 5 Million |
Keywords | Cocrystal Pharma, Cocrystal Pharma Inc, Co Crystal Pharma, Cocpd Mandatory Reverse Split |
Competitors | Abivax, Alios BioPharma, Chimerix, Inc., NeurOp, Inc., Sagimet Biosciences |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 54 Companies, NAICS Code 32 Companies, NAICS Code 541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular Cocrystal Pharma, Inc. employee's phone or email?
The Cocrystal Pharma, Inc. annual revenue was $6 million in 2024.
Gary Wilcox is the Vice Chairman of the Board of Directors of Cocrystal Pharma, Inc..
14 people are employed at Cocrystal Pharma, Inc..
Cocrystal Pharma, Inc. is based in Bothell, Washington.
The NAICS codes for Cocrystal Pharma, Inc. are [32541, 54, 32, 541, 3254, 325].
The SIC codes for Cocrystal Pharma, Inc. are [28, 283].